IARTINTEGRA LIFESCIENCES HOLDIN...

Nasdaq integralife.com


$ 20.37 $ -0.17 (-0.83 %)    

Wednesday, 28-Aug-2024 15:59:48 EDT
QQQ $ 468.16 $ -5.41 (-1.13 %)
DIA $ 411.36 $ -1.55 (-0.38 %)
SPY $ 558.32 $ -3.26 (-0.58 %)
TLT $ 97.88 $ -0.12 (-0.12 %)
GLD $ 231.76 $ -1.64 (-0.7 %)
$ 20.35
$ 20.32
$ 20.33 x 100
$ 20.35 x 100
$ 20.10 - $ 20.38
$ 20.10 - $ 45.42
529,524
na
1.58B
$ 1.11
$ 66.76
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-29-2024 06-30-2024 10-Q
2 05-06-2024 03-31-2024 10-Q
3 02-28-2024 12-31-2023 10-K
4 10-25-2023 09-30-2023 10-Q
5 07-27-2023 06-30-2023 10-Q
6 04-26-2023 03-31-2023 10-Q
7 02-22-2023 12-31-2022 10-K
8 10-26-2022 09-30-2022 10-Q
9 07-27-2022 06-30-2022 10-Q
10 04-27-2022 03-31-2022 10-Q
11 02-24-2022 12-31-2021 10-K
12 11-02-2021 09-30-2021 10-Q
13 07-29-2021 06-30-2021 10-Q
14 04-29-2021 03-31-2021 10-Q
15 02-23-2021 12-31-2020 10-K
16 10-29-2020 09-30-2020 10-Q
17 08-10-2020 06-30-2020 10-Q
18 05-07-2020 03-31-2020 10-Q
19 02-21-2020 12-31-2019 10-K
20 10-25-2019 09-30-2019 10-Q
21 07-25-2019 06-30-2019 10-Q
22 04-29-2019 03-31-2019 10-Q
23 02-26-2019 12-31-2018 10-K
24 11-01-2018 09-30-2018 10-Q
25 07-26-2018 06-30-2018 10-Q
26 04-26-2018 03-31-2018 10-Q
27 03-01-2018 12-31-2017 10-K
28 10-26-2017 09-30-2017 10-Q
29 07-26-2017 06-30-2017 10-Q
30 04-26-2017 03-31-2017 10-Q
31 02-23-2017 12-31-2016 10-K
32 10-28-2016 09-30-2016 10-Q
33 07-28-2016 06-30-2016 10-Q
34 04-27-2016 03-31-2016 10-Q
35 02-26-2016 12-31-2015 10-K
36 11-04-2015 09-30-2015 10-Q
37 07-31-2015 06-30-2015 10-Q
38 05-01-2015 03-31-2015 10-Q
39 02-27-2015 12-31-2014 10-K
40 11-07-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 btig-maintains-sell-on-integra-lifesciences-lowers-price-target-to-20

BTIG analyst Ryan Zimmerman maintains Integra Lifesciences (NASDAQ:IART) with a Sell and lowers the price target from $22 to...

 citigroup-maintains-sell-on-integra-lifesciences-lowers-price-target-to-20

Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Sell and lowers the price target from $...

 jmp-securities-maintains-market-outperform-on-integra-lifesciences-lowers-price-target-to-35

JMP Securities analyst David Turkaly maintains Integra Lifesciences (NASDAQ:IART) with a Market Outperform and lowers the pr...

 truist-securities-maintains-hold-on-integra-lifesciences-lowers-price-target-to-26

Truist Securities analyst Richard Newitter maintains Integra Lifesciences (NASDAQ:IART) with a Hold and lowers the price tar...

 citigroup-downgrades-integra-lifesciences-to-sell-lowers-price-target-to-23

Citigroup analyst Joanne Wuensch downgrades Integra Lifesciences (NASDAQ:IART) from Neutral to Sell and lowers the price tar...

 btig-downgrades-integra-lifesciences-to-sell-announces-22-price-target

BTIG analyst Ryan Zimmerman downgrades Integra Lifesciences (NASDAQ:IART) from Neutral to Sell and announces $22 price target.

 integra-lifesciences-expects-fy24-revenue-of-1609b-1629b-prior-1672b-1687b-vs-1676b-est-adj-eps-of-241-257-prior-301-311-vs-304-est

2024 Outlook For the full year 2024, the Company is updating its revenue and adjusted EPS expectations to $1.609 to $1.629 bil...

 integra-lifesciences-expects-q3-revenue-of-372m-382m-vs-43211m-est-adj-eps-of-036-044-vs-085-est

2024 Outlook For the full year 2024, the Company is updating its revenue and adjusted EPS expectations to $1.609 to $1.629 bil...

 truist-securities-maintains-hold-on-integra-lifesciences-raises-price-target-to-32

Truist Securities analyst Richard Newitter maintains Integra Lifesciences (NASDAQ:IART) with a Hold and raises the price tar...

 morgan-stanley-maintains-underweight-on-integra-lifesciences-raises-price-target-to-27

Morgan Stanley analyst Drew Ranieri maintains Integra Lifesciences (NASDAQ:IART) with a Underweight and raises the price tar...

 integra-lifesciences-provides-updated-plans-to-restart-the-manufacture-of-primatrix-and-surgimend-at-its-new-manufacturing-facility-in-braintree-massachusetts

Integra LifeSciences Holdings Corporation (NASDAQ:IART), a leading global medical technology company, is announcing its plans t...

 citigroup-maintains-neutral-on-integra-lifesciences-raises-price-target-to-30

Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Neutral and raises the price target fro...

 citigroup-maintains-neutral-on-integra-lifesciences-raises-price-target-to-28

Citigroup analyst Joanne Wuensch maintains Integra Lifesciences (NASDAQ:IART) with a Neutral and raises the price target fro...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION